Table 4.
Treatments administered to 571 cats before initial sample submission and their association with positive polymerase chain reaction (PCR) test results for Tritrichomonas foetus based on results of logistic regression
| Prior treatment administered | Number (%) of catsa | Number (%) of cats with positive PCR test result | Compared to no treatment | ||
|---|---|---|---|---|---|
| OR | 95% CI | P value | |||
| Metronidazole | 322 (56) | 39 (12) | 0.68 | 0.40‐1.14 | 0.14 |
| Anthelmintics | 172 (30) | 23 (13) | 1.09 | 0.61‐1.93 | 0.78 |
| Ronidazole | 103 (18) | 19 (18) | 1.00 | 0.51‐1.89 | 0.99 |
| Probiotics | 96 (17) | 12 (13) | 0.91 | 0.44‐1.76 | 0.79 |
| Albon or ponazuril | 87 (15) | 9 (10) | 0.72 | 0.31‐1.53 | 0.41 |
| Steroids | 70 (12) | 9 (13) | 1.01 | 0.44‐2.08 | 0.98 |
| Systemic antibiotics | 51 (9) | 9 (18) | 0.36 | 0.09‐1.03 | 0.10 |
| Tylosin | 32 (6) | 3 (9) | 0.40 | 0.06‐1.40 | 0.23 |
| No treatment | 62 (11) | 2 (3) | ‐ | ‐ | ‐ |
Note: Odds ratio (OR), 95% confidence interval (CI), and P value for significant association with positive results of PCR testing for T. foetus are shown for each variable as compared to no treatment.
a
Individual cats may have received >1 treatment and therefore may appear in >1 group.